The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands.
Publication year
2013Source
Leukemia Research, 37, 3, (2013), pp. 245-50ISSN
Annotation
01 maart 2013
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Haematology
Journal title
Leukemia Research
Volume
vol. 37
Issue
iss. 3
Page start
p. 245
Page end
p. 50
Subject
N4i 2: Invasive mycoses and compromised host ONCOL 3: Translational researchAbstract
The aim of this study was to calculate the costs of the current initial treatment of acute myeloid leukemia. Resource use was collected for 202 patients who started with intensive chemotherapy in 2008 or 2009. The costs of the first induction course were significantly higher than the costs of the second induction course. Allogeneic transplantation from a matched unrelated donor was significantly more expensive than the other consolidation treatments. In-hospital stay was the major cost driver in the treatment of AML. Research regarding possibilities of achieving the same or better health outcome with lower costs is warranted.
This item appears in the following Collection(s)
- Academic publications [245284]
- Faculty of Medical Sciences [93207]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.